Diaceutics (LSE:DXRX) Interest Expense : £-0.05 Mil (TTM As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Diaceutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Diaceutics's interest expense for the six months ended in Jun. 2024 was £ -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Diaceutics's Operating Income for the six months ended in Jun. 2024 was £ -3.59 Mil. Diaceutics's Interest Expense for the six months ended in Jun. 2024 was £ -0.03 Mil. Diaceutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Diaceutics Interest Expense Historical Data

The historical data trend for Diaceutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diaceutics Interest Expense Chart

Diaceutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.22

-0.05

-0.09

-0.12

-0.07

Diaceutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial										-0.07	-0.05	-0.04	-0.02	-0.03

Diaceutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.05 Mil.

Diaceutics (LSE:DXRX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Diaceutics's Interest Expense for the six months ended in Jun. 2024 was £-0.03 Mil. Its Operating Income for the six months ended in Jun. 2024 was £-3.59 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was £0.98 Mil.

Diaceutics's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Diaceutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Diaceutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diaceutics PLC (LSE:DXRX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

7DC:Germany

Address

Kings Hall Health and Wellbeing Park, Dataworks, First Floor, Building Two, Antrim, Belfast, GBR, BT9 6GW

Website

https://www.diaceutics.com

Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives.

Diaceutics Headlines

No Headlines